✦ LIBER ✦

P71. The bone degradation marker CTX is a unique marker for disease progression in multiple myeloma

✍ Scribed by Thomas Lund; Jean-Marie Delaissé; Niels Abildgaard; Katarzyna Kupisiewicz; Torben Plesner

Book ID: 116395292
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 29 KB
Volume: 34
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2008.03.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tartrate-resistant acid phosphatase isof

Tartrate-resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma

✍ Evangelos Terpos; Josu de la Fuente; Richard Szydlo; Evdoxia Hatjiharissi; Nora 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 80 KB

## Abstract Tartrate‐resistant acid phosphatase isoform‐5b (TRACP‐5b), a new marker reflecting osteoclast activity, and osteoprotegerin (OPG) were measured in 121 patients with multiple myeloma (MM) at diagnosis, and in 63 of them during pamidronate administration, to define their correlation with

sICAM-1 is not a marker for disease acti

sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis - a cross-sectional pilot study

✍ Peter Flachenecker; Stefan Jung; Peter Rieckmann; Klaus V. Toyka 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 227 KB